These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 36750145

  • 1. The small GTPase regulatory protein Rac1 drives podocyte injury independent of cationic channel protein TRPC5.
    Polat OK, Isaeva E, Sudhini YR, Knott B, Zhu K, Noben M, Suresh Kumar V, Endlich N, Mangos S, Reddy TV, Samelko B, Wei C, Altintas MM, Dryer SE, Sever S, Staruschenko A, Reiser J.
    Kidney Int; 2023 Jun; 103(6):1056-1062. PubMed ID: 36750145
    [Abstract] [Full Text] [Related]

  • 2. Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular disease.
    Kistler AD, Singh G, Altintas MM, Yu H, Fernandez IC, Gu C, Wilson C, Srivastava SK, Dietrich A, Walz K, Kerjaschki D, Ruiz P, Dryer S, Sever S, Dinda AK, Faul C, Reiser J.
    J Biol Chem; 2013 Dec 20; 288(51):36598-609. PubMed ID: 24194522
    [Abstract] [Full Text] [Related]

  • 3. TRPC Channels in Proteinuric Kidney Diseases.
    Hall G, Wang L, Spurney RF.
    Cells; 2019 Dec 23; 9(1):. PubMed ID: 31877991
    [Abstract] [Full Text] [Related]

  • 4. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
    Szabó T, Ambrus L, Zákány N, Balla G, Bíró T.
    Acta Physiol Hung; 2015 Sep 23; 102(3):241-51. PubMed ID: 26551740
    [Abstract] [Full Text] [Related]

  • 5. The Calcium-Dependent Protease Calpain-1 Links TRPC6 Activity to Podocyte Injury.
    Verheijden KAT, Sonneveld R, Bakker-van Bebber M, Wetzels JFM, van der Vlag J, Nijenhuis T.
    J Am Soc Nephrol; 2018 Aug 23; 29(8):2099-2109. PubMed ID: 29954830
    [Abstract] [Full Text] [Related]

  • 6. A novel gain-of-function mutation in transient receptor potential C6 that causes podocytes injury.
    Yu M, Hu J, Ju T, Wang R, Wang M, Gao C, Xia Z.
    Cell Mol Biol (Noisy-le-grand); 2024 May 27; 70(5):284-288. PubMed ID: 38814201
    [Abstract] [Full Text] [Related]

  • 7. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease.
    Sonneveld R, Ferrè S, Hoenderop JG, Dijkman HB, Berden JH, Bindels RJ, Wetzels JF, van der Vlag J, Nijenhuis T.
    Am J Pathol; 2013 Apr 27; 182(4):1196-204. PubMed ID: 23385000
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.
    Nijenhuis T, Sloan AJ, Hoenderop JG, Flesche J, van Goor H, Kistler AD, Bakker M, Bindels RJ, de Boer RA, Möller CC, Hamming I, Navis G, Wetzels JF, Berden JH, Reiser J, Faul C, van der Vlag J.
    Am J Pathol; 2011 Oct 27; 179(4):1719-32. PubMed ID: 21839714
    [Abstract] [Full Text] [Related]

  • 9. Insulin increases surface expression of TRPC6 channels in podocytes: role of NADPH oxidases and reactive oxygen species.
    Kim EY, Anderson M, Dryer SE.
    Am J Physiol Renal Physiol; 2012 Feb 01; 302(3):F298-307. PubMed ID: 22031853
    [Abstract] [Full Text] [Related]

  • 10. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases.
    Ilatovskaya DV, Staruschenko A.
    Am J Physiol Renal Physiol; 2015 Sep 01; 309(5):F393-7. PubMed ID: 26084930
    [Abstract] [Full Text] [Related]

  • 11. A small-molecule inhibitor of TRPC5 ion channels suppresses progressive kidney disease in animal models.
    Zhou Y, Castonguay P, Sidhom EH, Clark AR, Dvela-Levitt M, Kim S, Sieber J, Wieder N, Jung JY, Andreeva S, Reichardt J, Dubois F, Hoffmann SC, Basgen JM, Montesinos MS, Weins A, Johnson AC, Lander ES, Garrett MR, Hopkins CR, Greka A.
    Science; 2017 Dec 08; 358(6368):1332-1336. PubMed ID: 29217578
    [Abstract] [Full Text] [Related]

  • 12. TRPC channels: Regulation, dysregulation and contributions to chronic kidney disease.
    Dryer SE, Roshanravan H, Kim EY.
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun 01; 1865(6):1041-1066. PubMed ID: 30953689
    [Abstract] [Full Text] [Related]

  • 13. TRPC5 Does Not Cause or Aggravate Glomerular Disease.
    Wang X, Dande RR, Yu H, Samelko B, Miller RE, Altintas MM, Reiser J.
    J Am Soc Nephrol; 2018 Feb 01; 29(2):409-415. PubMed ID: 29061651
    [Abstract] [Full Text] [Related]

  • 14. Antagonistic regulation of actin dynamics and cell motility by TRPC5 and TRPC6 channels.
    Tian D, Jacobo SM, Billing D, Rozkalne A, Gage SD, Anagnostou T, Pavenstädt H, Hsu HH, Schlondorff J, Ramos A, Greka A.
    Sci Signal; 2010 Oct 26; 3(145):ra77. PubMed ID: 20978238
    [Abstract] [Full Text] [Related]

  • 15. Gq signaling causes glomerular injury by activating TRPC6.
    Wang L, Jirka G, Rosenberg PB, Buckley AF, Gomez JA, Fields TA, Winn MP, Spurney RF.
    J Clin Invest; 2015 May 26; 125(5):1913-26. PubMed ID: 25844902
    [Abstract] [Full Text] [Related]

  • 16. Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease.
    Krall P, Canales CP, Kairath P, Carmona-Mora P, Molina J, Carpio JD, Ruiz P, Mezzano SA, Li J, Wei C, Reiser J, Young JI, Walz K.
    PLoS One; 2010 Sep 20; 5(9):e12859. PubMed ID: 20877463
    [Abstract] [Full Text] [Related]

  • 17. Canonical transient receptor potential channel (TRPC)3 and TRPC6 associate with large-conductance Ca2+-activated K+ (BKCa) channels: role in BKCa trafficking to the surface of cultured podocytes.
    Kim EY, Alvarez-Baron CP, Dryer SE.
    Mol Pharmacol; 2009 Mar 20; 75(3):466-77. PubMed ID: 19052171
    [Abstract] [Full Text] [Related]

  • 18. Activation of NFAT signaling in podocytes causes glomerulosclerosis.
    Wang Y, Jarad G, Tripathi P, Pan M, Cunningham J, Martin DR, Liapis H, Miner JH, Chen F.
    J Am Soc Nephrol; 2010 Oct 20; 21(10):1657-66. PubMed ID: 20651158
    [Abstract] [Full Text] [Related]

  • 19. Tetrandrine Suppresses Transient Receptor Potential Cation Channel Protein 6 Overexpression- Induced Podocyte Damage via Blockage of RhoA/ROCK1 Signaling.
    Yu J, Zhu C, Yin J, Yu D, Wan F, Tang X, Jiang X.
    Drug Des Devel Ther; 2020 Oct 20; 14():361-370. PubMed ID: 32095070
    [Abstract] [Full Text] [Related]

  • 20. TRPC6 channels and their binding partners in podocytes: role in glomerular filtration and pathophysiology.
    Dryer SE, Reiser J.
    Am J Physiol Renal Physiol; 2010 Oct 20; 299(4):F689-701. PubMed ID: 20685822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.